CY1115455T1 - Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας - Google Patents

Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας

Info

Publication number
CY1115455T1
CY1115455T1 CY20141100171T CY141100171T CY1115455T1 CY 1115455 T1 CY1115455 T1 CY 1115455T1 CY 20141100171 T CY20141100171 T CY 20141100171T CY 141100171 T CY141100171 T CY 141100171T CY 1115455 T1 CY1115455 T1 CY 1115455T1
Authority
CY
Cyprus
Prior art keywords
dimethylamino
treatment
compounds
fenylo
propanium
Prior art date
Application number
CY20141100171T
Other languages
Greek (el)
English (en)
Inventor
Thomas Christoph
Babette-Yvonne Kögel
Elmar Friderichs
Muriel Dr Meen
Original Assignee
Grünenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39345501&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1115455(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH
Publication of CY1115455T1 publication Critical patent/CY1115455T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY20141100171T 2007-03-12 2014-02-28 Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας CY1115455T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007012165A DE102007012165A1 (de) 2007-03-12 2007-03-12 Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
EP08716394.5A EP2117525B1 (de) 2007-03-12 2008-03-10 Verwendung von 1-phenyl-3-dimethylamino-propanverbindungen zur therapie des neuropathieschmerzes

Publications (1)

Publication Number Publication Date
CY1115455T1 true CY1115455T1 (el) 2017-01-04

Family

ID=39345501

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100171T CY1115455T1 (el) 2007-03-12 2014-02-28 Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας

Country Status (13)

Country Link
US (2) US20080269326A1 (enExample)
EP (1) EP2117525B1 (enExample)
JP (5) JP2010520907A (enExample)
CA (1) CA2680771C (enExample)
CY (1) CY1115455T1 (enExample)
DE (1) DE102007012165A1 (enExample)
DK (1) DK2117525T3 (enExample)
ES (1) ES2452830T3 (enExample)
HR (1) HRP20140280T1 (enExample)
PL (1) PL2117525T3 (enExample)
PT (1) PT2117525E (enExample)
SI (1) SI2117525T1 (enExample)
WO (1) WO2008110323A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2582366B1 (en) * 2010-06-15 2015-10-28 Grünenthal GmbH Pharmaceutical combination for the treatment of pain
MX341072B (es) * 2010-07-23 2016-08-05 Grünenthal Gmbh * Sales o co-cristales de 3-(3-dimetilamino-1-etil-2-metil-propil)-f enol.
WO2012051246A1 (en) 2010-10-12 2012-04-19 Ratiopharm Gmbh Tapentadol hydrobromide and crystalline forms thereof
AU2012224954C1 (en) * 2011-03-04 2017-04-06 Grünenthal GmbH Semisolid aqueous pharmaceutical composition containing tapentadol
CN103501775A (zh) * 2011-03-04 2014-01-08 格吕伦塔尔有限公司 他喷他多的胃肠外给药
EP3597182A1 (en) * 2011-03-04 2020-01-22 Grünenthal GmbH Aqueous pharmaceutical formulation of tapentadol for oral administration
JP2019142972A (ja) * 2011-03-04 2019-08-29 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールの非経口的投与
JP6040219B2 (ja) * 2011-04-05 2016-12-07 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 三叉神経因性痛に伴う疼痛の治療用タペンタドール
SI2694049T1 (sl) 2011-04-05 2019-01-31 Gruenenthal Gmbh Tapentadol za preprečevanje razvoja kronične bolečine
HUE049308T2 (hu) 2011-04-29 2020-09-28 Gruenenthal Gmbh Tapentadol alkalmazása depresszió és szorongás megelõzésére és kezelésére
US8853393B2 (en) 2011-07-29 2014-10-07 Anhui New Star Pharmaceutical Development Co., Ltd. Intermediate for preparing tapentadol or analogues thereof
TR201802128T4 (tr) * 2011-07-29 2018-03-21 Gruenenthal Gmbh İntratekal veya epidural yolla 3-[(1s,2s)-3-(dimetilamino)-1-etil-2-metilpropil]fenol uygulaması.
CN103159633B (zh) * 2012-07-06 2015-08-12 江苏恩华药业股份有限公司 他喷他多的制备方法及用于制备他喷他多的化合物
EP2808319A1 (en) 2013-05-31 2014-12-03 Arevipharma GmbH 3-[3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex
CN107847471A (zh) * 2015-03-27 2018-03-27 格吕伦塔尔有限公司 他喷他多肠胃外给药的稳定制剂
PE20190908A1 (es) 2016-09-23 2019-06-26 Gruenenthal Chemie Formulacion estable para la administracion parenteral de tapentadol
EP3585370A1 (en) 2017-02-23 2020-01-01 Grünenthal GmbH Tapentadol as local anesthetic
CN114788814B (zh) * 2021-01-26 2023-10-13 浙江创新生物有限公司 一种高稳定性的注射用达托霉素组合物及其制备方法和其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
ES2640404T3 (es) * 2002-11-22 2017-11-02 Grünenthal GmbH Combinación de analgésicos seleccionados con inhibidores de la COX II
BRPI0710682B8 (pt) * 2006-04-28 2021-05-25 Gruenenthal Gmbh combinação farmacêutica compreendendo 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol e paracetamol

Also Published As

Publication number Publication date
DK2117525T3 (da) 2014-02-03
ES2452830T3 (es) 2014-04-02
WO2008110323A1 (de) 2008-09-18
PL2117525T3 (pl) 2014-05-30
HRP20140280T1 (hr) 2014-04-25
EP2117525A1 (de) 2009-11-18
JP2013256540A (ja) 2013-12-26
JP2019196405A (ja) 2019-11-14
EP2117525B1 (de) 2013-12-25
JP2010520907A (ja) 2010-06-17
PT2117525E (pt) 2014-02-14
DE102007012165A1 (de) 2008-09-18
CA2680771C (en) 2015-11-17
SI2117525T1 (sl) 2014-03-31
US20080269326A1 (en) 2008-10-30
US8536130B2 (en) 2013-09-17
JP6745959B2 (ja) 2020-08-26
US20100311842A1 (en) 2010-12-09
JP2018030886A (ja) 2018-03-01
JP6081337B2 (ja) 2017-02-15
JP2016056188A (ja) 2016-04-21
CA2680771A1 (en) 2008-09-18

Similar Documents

Publication Publication Date Title
CY1115455T1 (el) Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας
ATE534378T1 (de) Titrierung von tapentadol
MA32562B1 (fr) Composes organiques pour la cicatrisation de lesion
CY1112067T1 (el) Χρηση φλιμπανσερινης για την θεραπεια διαταραχων προ-εμμηνοπαυσιακης σεξουαλικης επιθυμιας
CY1113024T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου για τη θεραπεια της εξαρτησης ουσιων
CY1115254T1 (el) Φαρμακευτικα διαλυματα, διαδικασιες για την παρασκευη τους και θεραπευτικες χρησεις
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
CY1111454T1 (el) Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων
EA201170521A1 (ru) Новые соединения
CY1122416T1 (el) Φαρμακα τα οποια περιεχουν κρυσταλλικες τροποποιησεις (1r,2r)-3-(3-δimeθyλamino-1-αιθυλο-2-μεθυλο-προπυλο)-φαινολης
CL2009000402A1 (es) Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras.
CY1115975T1 (el) Ταπενταδολη για τη θεραπεια πονου σε αρθριτιδα
MX2011002966A (es) Formas de dosificacion farmaceutica que comprenden poli (e-caprolactona).
EA201000105A1 (ru) Химические соединения
EA201071144A1 (ru) Гетероциклические производные
IN2012DN01435A (enExample)
EA201200098A1 (ru) Конденсированные имидазолы и содержащие их композиции, предназначенные для лечения паразитарных заболеваний, таких как, например, малярия
LT2451482T (lt) Kombinuota terapija, skirta diabeto gydymui
EA201170356A1 (ru) Полиморфные и аморфные формы лакозамида и аморфные композиции
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
EA201100255A1 (ru) 5-алкинилпиримидины
EA201200046A1 (ru) Новые соединения, фармацевтическая композиция и связанные с ними способы
UA108494C2 (uk) Застосування (rs)-s-цикропропіл-s-(4-{[4-{[(1r,2r)-2-гідрокси-1-метилпропіл]окси}-5-(трифторметил)піримідин-2-іл]аміно}феніл)сульфоксіміду для лікування пухлин
CY1114760T1 (el) Θεραπευτικη αγωγη αθηροσκληρωσης
EA201170672A1 (ru) Соединения, пригодные для лечения целлюлита